Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy Electronic Site License Strategic Perspectives 2001: Narcolepsy - Specific Drugs are Waking up the Market Datamonitor, Sep 2001   Description     Table of Contents        Enquire before Buying    Send to a Friend   Whilst narcolepsy is not a prevalent disorder, the recentsuccess of the first narcolepsy specific drug, Provigil(modafinil) has created interest in this previously neglectedmarket. With its superior efficacy and safety profilecompared to the previous gold standard treatment, theCNS stimulants, Provigil is expected to continue itssuccess for the foreseeable future.However, Provigil is only effective at treating one of thesymptoms of narcolepsy, excessive daytime sleepiness,and does not treat another commonly experiencedsymptom, cataplexy. Another narcolepsy specific drug,Xyrem (sodium oxybate), which is likely to be availablesoon, seems set to fill this unmet need and become verysuccessful in the future. Customers who bought this item also bought Drugs of Tomorrow 2001: Diabetes Commercial Perspectives: Sleep Disorders - Insomnia, Narcolepsy and Restless Leg Syndrome The Global Market For Sleep-Wake Disorders, 2005-2012: Trends, Opportunities, and Insights in A High-Value Cns Therapy Area Beyond The Blockbuster Drug: Strategies For Nichebuster Drugs, Targeted Therapies and Personalized Medicine. The Latin American Market for Generic Drugs - A Comparative Study of 7 Key Markets Chinese Markets for Cancer Treatment Drugs Antiageing and Life Enhancement Pharmacotherapeutics: Rejuvenating Drug Markets To 2012 and Beyond The Global Market For Hormonal Contraceptives and Infertility Drugs, 2005-2012

		Top of page

All rights reserved. Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster